GRANULES: Record FY26 revenue and margin gains led by complex generics and CDMO growth
GRANULES: Record FY26 revenue and margin gains led by complex generics and CDMO growth
GRANULES: Record FY26 revenue and margin gains led by complex generics and CDMO growth
Sector
BROAD_MARKET
News Type
MARKET
Impact Level
HIGH
AI Sentiment
POSITIVE
Published
03 May 2026
📎 Sources
Quartr | https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:3268043:0-granules-record-fy26-revenue-and-margin-gains-led-by-complex-generics-and-cdmo-growth/